| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Aflatoxin | Aflatoxin B1 | VL5520002 | View CAS 1162-65-8 |
| Aflatoxin | Aflatoxin B2 | VL5520003 | View CAS 7220-81-7 |
| Aflatoxin | Aflatoxin M2 | VL5520001 | View CAS 6885-57-0 |
Aflatoxin impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Aflatoxin | Aflatoxin B1 | VL5520002 | View CAS 1162-65-8 |
| Aflatoxin | Aflatoxin B2 | VL5520003 | View CAS 7220-81-7 |
| Aflatoxin | Aflatoxin M2 | VL5520001 | View CAS 6885-57-0 |
| Catalogue No. | VL5520002 |
| CAS No. | 1162-65-8 |
| Molecular Formula | C17H12O6 |
| Molecular Weight | 312.28 |
| Parent drug | Aflatoxin |
| IUPAC Name | (6aR, 9aS)-4-methoxy-3, 3a, 9a, 11a-tetrahydrocyclopenta[c]furo[3', 2':4, 5]furo[2, 3-h]chromene-1, 11(2H, 6aH)-dione |
| Synonyms | N/A |
| References | Guengerich, F. Peter., et al. “Activation and Detoxication of Aflatoxin B1.” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 402, no. 1-2, June 1998, pp. 121–28, https://doi.org/10.1016/s0027-5107(97)00289-3. |
| Status | Under Development |
| ListName | Aflatoxin B1 |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
